[Alzemon: a prospective follow-up study of eslicarbazepine acetate monotherapy in patients with newly diagnosed epilepsy].
Hernández-Rubio L, Asensio-Asensio M, Tortosa-Conesa D, Alfaro-Sáez A, García-Escrivá A, Díaz-Román M, Montoya J, Méndez-Miralles MA, Bertol-Alegre V, Castro-Vilanova MD, Galiano ML, Blanco-Cantó ME, López-González F.
Hernández-Rubio L, et al. Among authors: blanco canto me.
Rev Neurol. 2021 Apr 16;72(8):263-268. doi: 10.33588/rn.7208.2020593.
Rev Neurol. 2021.
PMID: 33851715
Free article.
Spanish.